Tor Vergata University-Hospital in the Beginning of COVID-19-Era: Experience and Recommendation for Breast Cancer Patients
Oreste Claudio Buonomo, Marco Materazzo, Marco Pellicciaro, Jonathan Caspi, Emilio Piccione, Gianluca Vanni, Oreste Claudio Buonomo, Marco Materazzo, Marco Pellicciaro, Jonathan Caspi, Emilio Piccione, Gianluca Vanni
Abstract
COVID-19 has been officially declared as a pandemic by the WHO. Italy was the first European country to be strongly affected by this outbreak. All elective and health promotion activities were reduced. Accordingly, Italian Breast Units and breast cancer (BC) screening programs scaled down significantly their activities. The aim of this study was to evaluate measures that could potentially reduce the clinical impact of COVID-19 on BC patients. Temporary recommendations are needed that could assist specialists in preventing COVID-19 infection and optimizing resources for diagnosis and treatment of BC patients.
Keywords: Breast cancer; COVID-19; Italy; screening program; tailored treatment.
Conflict of interest statement
The Authors declare no conflicts of interest regarding this study.
Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
Source: PubMed